ArticleCurrent cancer drug targets2026

GPX4 Inhibition Enhances the Antitumor Effect of PARP Inhibitor on Homologous Recombination Proficient Ovarian Cancer Cells.

Jiaxin Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.